Navigation Links
Cellectis bioresearch Appoints Wako as Exclusive Distributor of its Genome Customization Solutions in Japan

PARIS and OSAKA, Japan, May 18, 2011 /PRNewswire/ -- Cellectis bioresearch, a subsidiary of Cellectis (Alternext: ALCLS) and genome customization specialist, has appointed Wako Pure Chemical Industries as its distributor in Japan for the Company's broad portfolio of research products and services, including the recently launched TALEN(1) Access™. Wako Pure Chemical Industries is a leading distributor of research products in Japan.

"In February 2011, we launched our revolutionary rapid, custom-designed TALEN service that enables access to genome customization tools to a large audience of life science researchers, due to its affordable price,” said Luc Selig, VP Sales & Marketing at Cellectis bioresearch. "We are now targeting rapid global distribution and Japan is a major player in life science research. Wako will allow us to enter this important market effectively, thanks to its key position."

Cellectis bioresearch's current portfolio includes more than 200 product references that address the genome customization requirements of life science researchers. In the last 12 months, Cellectis bioresearch has deployed its own sales force in Europe and the USA and has appointed agents and distributors in Canada and India. Online purchase is also available through the Cellectis bioresearch website.

About Cellectis bioresearch

Cellectis bioresearch was incorporated as a subsidiary of Cellectis (Alternext: ALCLS) in June 2008. It provides life science researchers with ready- and easy-to-use tools for genome customization. These tools, based on sequence specific nucleases, enable the engineering of cells with optimized features for drug discovery, protein production and gene functional studies.

The kits can be purchased online from More information on the website.

About Cellectis

Cellectis improves life by applying its genome engineering expertise to a broad range of applications, including human therapeutics, bioresearch and agriculture. Cellectis is listed on the NYSE-Euronext Alternext market (code: ALCLS) in Paris.

More information at  

Follow Cellectis on Twitter at

About Wako Pure Chemical Industries, Ltd.

Wako Pure Chemical Industries, Ltd., which is headquartered at Osaka (Japan) is the Japan's largest manufacture of laboratory chemical, specialty chemicals, and diagnostic reagents. Wako was founded in 1922 and currently has 1,440 employees, locating offices in all over in Japan, Europe and US. Wako contribute to the development of science and technology and create a prosperous future.

For further information, please go to:


This press release and the information contained herein do not constitute an offer to sell or subscribe, or a solicitation of an offer to buy or subscribe, for shares in Cellectis in any country. This press release contains forward-looking statements that relate to the Company's objectives based on the current expectations and assumptions of the Company's management only and involve unforeseeable risk and uncertainties that could cause the Company to fail to achieve the objectives expressed by the forward-looking statements above.

(1) TALEN: Transcription Activator-Like Effector Nucleases

SOURCE Cellectis
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Cellectis and Caisse des Depots Sign Agreement on a Project for the Industrial Development of iPS Cells
2. Cellectis Receives Payment for License to Homologous Recombination Patents
3. Cellectis Publishes 2010 Financial Results
4. Cellectis and the Etablissement Francais du Sang Launch StemRed, a Program to Produce Red Blood Cells From Stem Cells
5. Cellectis bioresearch First to Launch Revolutionary Custom TAL Nuclease Service
6. Cellectis Meganuclease Technology Used to Efficiently Prevent Viral Infection
7. Cellectis bioresearch Announces the First TGCA Winner
8. Cellectis bioresearch Signs Non-Exclusive License With Evrogen for Access to Fluorescent Proteins
9. Cellectis Plant Sciences Licenses Plant Transformation Technology for Corn and Rice
10. Cellectis and the Center for iPS Cells Research and Application Enter Collaboration
11. Cellectis Plant Sciences Licenses Plant Transformation Technology From Midwest Oilseeds
Post Your Comments:
(Date:11/24/2015)... 24, 2015 Cepheid (NASDAQ: CPHD ) ... the following conference, and invited investors to participate via ...      Tuesday, December 1, 2015 at 11.00 a.m. Eastern ...      Tuesday, December 1, 2015 at 11.00 a.m. Eastern ... New York, NY      Tuesday, December 1, ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... metabolism. But unless it is bound to proteins, copper is also toxic to ... researchers at Worcester Polytechnic Institute (WPI) will conduct a systematic study of copper ...
(Date:11/24/2015)... Global, Inc., a worldwide provider of clinical research services headquartered in ... company has set a new quarterly earnings record in Q3 of ... for Q3 of 2014 to Q3 of 2015.   ... with the establishment of an Asia-Pacific office ... Kingdom and Mexico , with the ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... The Academy ... Special Interest Group (SIG), MultiGP, also known as Multirotor Grand Prix, to represent the ... last few years. Many AMA members have embraced this type of racing and several ...
Breaking Biology Technology:
(Date:11/19/2015)... , Nov. 19, 2015  Based on its in-depth ... Sullivan recognizes BIO-key with the 2015 Global Frost & ... Frost & Sullivan presents this award to the company ... to the needs of the market it serves. The ... meets and expands on customer base demands, the overall ...
(Date:11/18/2015)... 2015 --> ... market report titled  Gesture Recognition Market - Global Industry ... 2021. According to the report, the global gesture recognition market was valued ... reach US$29.1 bn by 2021, at a CAGR of ... America dominated the global gesture recognition market ...
(Date:11/17/2015)... 2015  Vigilant Solutions announces today that Mr. ... Directors. --> --> ... the partnership at TPG Capital, one of the largest ... Billion in revenue.  He founded and led TPG,s Operating ... companies, from 1997 to 2013.  In his first role, ...
Breaking Biology News(10 mins):